Transforming Vascular Access

We are solving the greatest challenges in vascular access.

Access Vascular is offering a suite of vascular access devices that use our novel, patented biomaterial featuring MIMIX™ technology which is designed to prevent the most common and costly complications in vascular access.

• Keep treatment moving forward with products that have demonstrated in clinical, in vivo and in vitro data to have a statistically significant reduction in complications compared to standard polyurethane catheters.*

• Tackle most avoidable complications like occlusions and replacements - no coatings, fillers or surface modifications.

• Provide better patient experience - fewer device replacements means fewer unnecessary needle sticks and fewer delays in treatment.

• Potential savings of up to $1.8 million in reduced complications for a large acute care hospital based on economic study.